CRPS was associated with temperature asymmetry, skin color asymmetry, asymmetric edema, motor changes, allodynia, and hyperalgesia.
Dsuvia, an opioid agonist, is a Schedule II controlled substance and is indicated for use in adults in a certified medically supervised healthcare setting.
Researchers sought to assess the short-term benefit and risk of ticagrelor with aspirin in patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack.
Patients undergoing lumbar spinal fusion surgery who were cannabis users consumed more opioids both prior to and after hospital discharge.
Health care providers are being urged to be alert for rash illnesses consistent with monkeypox.
Researchers evaluated the safety and efficacy of neuromuscular electric stimulation therapy in the reduction of knee osteoarthritis-related pain, stiffness, and function.
Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
The Quell neuromodulation device has received the FDA De Novo authorization for use as an aid in reducing the symptoms of fibromyalgia.
Sleep problems are not excessive in patients with newly diagnosed rheumatoid arthritis.
The totality of the evidence led the FDA to determine that the criteria for issuing an EUA had not been met.